209 related articles for article (PubMed ID: 15189367)
1. An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis.
Ormarsdóttir S; Mallmin H; Naessén T; Petrén-Mallmin M; Broomé U; Hultcrantz R; Lööf L
J Intern Med; 2004 Jul; 256(1):63-9. PubMed ID: 15189367
[TBL] [Abstract][Full Text] [Related]
2. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
[TBL] [Abstract][Full Text] [Related]
4. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
[TBL] [Abstract][Full Text] [Related]
5. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
Crippin JS; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797
[TBL] [Abstract][Full Text] [Related]
6. Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
Zein CO; Jorgensen RA; Clarke B; Wenger DE; Keach JC; Angulo P; Lindor KD
Hepatology; 2005 Oct; 42(4):762-71. PubMed ID: 16175618
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal bone loss in postmenopausal women with primary biliary cirrhosis and well-preserved liver function.
Ormarsdóttir S; Ljunggren O; Mallmin H; Olsson R; Prytz H; Lööf L
J Intern Med; 2002 Dec; 252(6):537-41. PubMed ID: 12472915
[TBL] [Abstract][Full Text] [Related]
8. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis.
Olsson R; Mattsson LA; Obrant K; Mellström D
Liver; 1999 Jun; 19(3):188-92. PubMed ID: 10395037
[TBL] [Abstract][Full Text] [Related]
11. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss.
Mizunuma H; Shiraki M; Shintani M; Gorai I; Makita K; Itoga S; Mochizuki Y; Mogi H; Iwaoki Y; Kosha S; Yasui T; Ishihara O; Kurabayashi T; Kasuga Y; Hayashi K
J Bone Miner Metab; 2006; 24(1):11-5. PubMed ID: 16369892
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
[TBL] [Abstract][Full Text] [Related]
14. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Bhattoa HP; Bettembuk P; Balogh A; Szegedi G; Kiss E
Osteoporos Int; 2004 May; 15(5):396-404. PubMed ID: 14676992
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
Levy C; Harnois DM; Angulo P; Jorgensen R; Lindor KD
Liver Int; 2005 Feb; 25(1):117-21. PubMed ID: 15698408
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Warming L; Ravn P; Christiansen C
Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
[TBL] [Abstract][Full Text] [Related]
17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
18. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Alhava E; Honkanen R; Jurvelin J; Saarikoski S
J Clin Endocrinol Metab; 1999 Feb; 84(2):546-52. PubMed ID: 10022414
[TBL] [Abstract][Full Text] [Related]
19. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
20. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
